Search or

𝛼SK

ENTITY

Shenzhen HepaLink Pharmaceutical (H) (9989 HK)

80

Analysis

Health Care • China

Shenzhen Hepalink Pharmaceutical Group Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.

more

Refresh

Exchange Announcement • 24 Nov 2025 18:35

For The 2025 First Extraordinary General Meeting To Be Held On Tuesday, December 16, 2025

Exchange Announcement • 24 Nov 2025 18:34

Notice Of The 2025 First Extraordinary General Meeting

Exchange Announcement • 24 Nov 2025 18:33

(1) Proposed Abolition Of The Supervisory Committee, Proposed Amendments To The Articles And Proposed Amendments To The Related Rules Of Procedures Of The Company; (2) Proposed Amendments To Certain Internal Corporate Governance Measures Of The Company; (3) Proposed Election Of An Independent Non-Executive Director; And (4) Notice Of The 2025 First Extraordinary General Meeting

Exchange Announcement • 24 Nov 2025 18:29

(1) Proposed Abolition Of The Supervisory Committee And The Proposed Amendments To The Articles Related Rules Of Procedures Of The Company And Certain Internal Corporate Governance Measures Of The Company; And (2) Expiration Of The Term Of Office Of An Independent Non-Executive Director And Proposed Election Of An Independent Non-Executive Director

Exchange Announcement • 30 Oct 2025 17:05

2025 Third Quarterly Report

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x